COVID-19

Increased support for countries to overcome COVID-19 pandemic

The fight against COVID-19 pandemic is ongoing. Bayer is helping worldwide with donations, products, and expertise in the areas of health and nutrition, for example through our partnership with CureVac to further develop and manufacture a vaccine. Part of our help activities include support to countries in need.

Since the beginning of the pandemic, we have donated more than EUR 29 Mio in products, supplies and funds to help fight Covid-19 in over 60 countries. Now we are extending the donations made so far by a further EUR 1.6 Mio with a special focus on India and Brazil.

Dr. Monika Lessl
Every day we hear how the Corona pandemic is pushing global health care to its limits. In some countries, these limits have already been exceeded. We remain concerned and want to support where help is most needed, because especially in a pandemic, we have a larger role to play in bringing to life our vision 'Health for all, hunger for none'."
Dr. Monika Lessl
,
Senior Vice President, Head of Corporate R&D and Social Innovation and Director of Bayer Foundation

India and Brazil are currently suffering from a severe second COVID-19 wave. We decided to help those two countries most in need and organize direct help on the ground through our partner organizations:

 

  • Bayer India has purchased 200,000 N95 masks, 1,100,000 3ply masks and oxygen concentrators to better equip hospitals and rural Public Health Centers. In addition, Bayer has re-purposed its existing 200NM3/hr Nitrogen plant at its manufacturing facility at Vapi, Gujarat to provide a permanent source of Oxygen supply to a local hospital.  Over 10,000 healthcare workers and members from the farming communities will receive psychological support to tide over mental health challenges. In the state of Maharashtra, Bayer will collaborate with the Government of Maharashtra, NASSCOM and WNS Global Services in managing 30 Intensive Care Unit beds via telemedicine solutions. Over the last 10 months, Bayer along with the state government, has converted its plant at Chittegaon, Aurangabad into an 80-bed COVID-care facility.  

 

  • UNICEF Brazil will use Bayer donations as part of an emergency plan in the Amazon and Semiarid region to combat the pandemic. Measures include widespread information about the pandemic, health promotion including mental health, and the adaptation of essential public services and education. These will be implemented together with local public authorities and key social leaders. In addition, UNICEF will distribute oximeters, digital thermometers and PPE in 7 states in the North and Northeast of Brazil. This will reach more than 90 communities in need, and the donated equipment can be used for up to 10 years after the pandemic.


Beyond help for India and Brazil as two countries in most need, Bayer is supporting the procurement of oxygen concentrators and the vaccine development for low-and-middle-income countries: 

 

  • Direct Relief will purchase 200 oxygen concentrators to equip healthcare providers in Covid-19 hot spot regions. Potential recipients include Direct Relief partners in Mexico, South America, Eastern Europe, Asia, and Africa where intensive care unit bed capacity is most strained due to increasing cases of severe Covid-19 diseases. Access to oxygen through the concentrators can help avoid intubation and the use of a mechanical ventilator.

 

  • The global nonprofit, PATH, is supporting the development of a low-cost, stable COVID-19 vaccine that can be sustainably accessible for and manufactured by low- and middle-income countries. The vaccine is a novel approach using Newcastle disease virus technology developed at the Icahn School of Medicine at Mount Sinai (ISMMS) and a stabilized spike protein (HexaPro) developed at the University of Texas in Austin (UT Austin). The vaccine is made in eggs like many influenza vaccines, so existing production infrastructure may be used to affordably manufacture large volumes of doses. Under license agreements with Mount Sinai and UT Austin, PATH is helping provide vaccine manufacturers in Vietnam, Thailand and Brazil access to the vaccine for development and is serving as a connector, facilitator, and technical advisor across the consortium. Bayer is supporting PATH’s technical advisory role in Vietnam as the country’s manufacturer advances Phase 1 and 2 clinical studies.


We are continuously monitoring the situation in the COVID-19 crisis countries and are ready to organize further support together with our partner organizations

Sign_Against_COVID-19_Bayer_Cross_RGB.png

 

Bayer against COVID-19


This is one of many examples of how Bayer is helping to fight the COVID-19 pandemic worldwide with donations, products and expertise. Learn more about our engagement in the fight against the COVID-19 pandemic here in our Corona hub and in our “Stronger Together against COVID-19” blog entries.